Literature DB >> 23458603

Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.

Rong Chen1, Conor P Daining, Haiguo Sun, Rheaclare Fraser, Stephanie L Stokes, Michael Leitges, Margaret E Gnegy.   

Abstract

The strength and duration of extracellular dopamine concentrations are regulated by the presynaptic dopamine transporter (DAT) and dopamine D2 autoreceptors (D2autoRs). There is a functional interaction between these two proteins. Activation of D2autoRs increases DAT trafficking to the surface whereas disruption of this interaction compromises activities of both proteins and alters dopaminergic transmission. Previously we reported that DAT expression and activity are subject to modulation by protein kinase Cβ (PKCβ). Here, we further demonstrate that PKCβ is integral for the interaction between DAT and D2autoR. Inhibition or absence of PKCβ abolished the communication between DAT and D2autoR. In mouse striatal synaptosomes and transfected N2A cells, the D2autoR-stimulated membrane insertion of DAT was abolished by PKCβ inhibition. Moreover, D2autoR-stimulated DAT trafficking is mediated by a PKCβ-extracellular signal-regulated kinase signaling cascade where PKCβ is upstream of extracellular signal-regulated kinase. The increased surface DAT expression upon D2autoR activation resulted from enhanced DAT recycling as opposed to reduced internalization. Further, PKCβ promoted accelerated DAT recycling. Our study demonstrates that PKCβ critically regulates D2autoR-activated DAT trafficking and dopaminergic signaling. PKCβ is a potential drug target for correcting abnormal extracellular dopamine levels in diseases such as drug addiction and schizophrenia.
© 2013 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458603      PMCID: PMC3660534          DOI: 10.1111/jnc.12229

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  50 in total

1.  Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.

Authors:  A Zapata; J M Witkin; T S Shippenberg
Journal:  Neuropharmacology       Date:  2001-09       Impact factor: 5.250

2.  Dopamine D3 receptors expressed by all mesencephalic dopamine neurons.

Authors:  J Diaz; C Pilon; B Le Foll; C Gros; A Triller; J C Schwartz; P Sokoloff
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

3.  A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions.

Authors:  P R Dunkley; J W Heath; S M Harrison; P E Jarvie; P J Glenfield; J A Rostas
Journal:  Brain Res       Date:  1988-02-16       Impact factor: 3.252

4.  Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.

Authors:  James D Foster; Benchaporn Pananusorn; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

5.  Immunodeficiency in protein kinase cbeta-deficient mice.

Authors:  M Leitges; C Schmedt; R Guinamard; J Davoust; S Schaal; S Stabel; A Tarakhovsky
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

6.  Ex vivo identification of protein-protein interactions involving the dopamine transporter.

Authors:  Gregory C Hadlock; Chad C Nelson; Anthony J Baucum; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurosci Methods       Date:  2011-02-01       Impact factor: 2.390

Review 7.  Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

Authors:  Jacob Eriksen; Trine Nygaard Jørgensen; Ulrik Gether
Journal:  J Neurochem       Date:  2010-01-18       Impact factor: 5.372

8.  Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization.

Authors:  Ekaterina Boudanova; Deanna M Navaroli; Zachary Stevens; Haley E Melikian
Journal:  Mol Cell Neurosci       Date:  2008-06-25       Impact factor: 4.314

9.  Mechanisms underlying the effects of amphetamine on particulate PKC activity.

Authors:  Cecilia T Giambalvo
Journal:  Synapse       Date:  2004-02       Impact factor: 2.562

10.  Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons.

Authors:  D Lu; H Yang; R H Lenox; M K Raizada
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

View more
  31 in total

1.  Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.

Authors:  Molly M McGinnis; Cody A Siciliano; Sara R Jones
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

2.  Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.

Authors:  Luke R Gabriel; Sijia Wu; Patrick Kearney; Karl D Bellvé; Clive Standley; Kevin E Fogarty; Haley E Melikian
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

Review 3.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 4.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

5.  Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation.

Authors:  Cody A Siciliano; Kaustuv Saha; Erin S Calipari; Steve C Fordahl; Rong Chen; Habibeh Khoshbouei; Sara R Jones
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

6.  The Dopamine Transporter Recycles via a Retromer-Dependent Postendocytic Mechanism: Tracking Studies Using a Novel Fluorophore-Coupling Approach.

Authors:  Sijia Wu; Rita R Fagan; Chayasith Uttamapinant; Lawrence M Lifshitz; Kevin E Fogarty; Alice Y Ting; Haley E Melikian
Journal:  J Neurosci       Date:  2017-08-28       Impact factor: 6.167

7.  Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.

Authors:  Zili Luo; Katelin E Ahlers-Dannen; Mackenzie M Spicer; Jianqi Yang; Stephanie Alberico; Hanna E Stevens; Nandakumar S Narayanan; Rory A Fisher
Journal:  JCI Insight       Date:  2019-05-23

Review 8.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

9.  Regulator of G protein signaling 6 is a critical mediator of both reward-related behavioral and pathological responses to alcohol.

Authors:  Adele Stewart; Biswanath Maity; Simon P Anderegg; Chantal Allamargot; Jianqi Yang; Rory A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

10.  Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter.

Authors:  Erin S Calipari; Mark J Ferris; Benjamin A Zimmer; David C S Roberts; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2013-05-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.